Fast Five Quiz: Tardive Dyskinesia Management

Christoph U. Correll, MD


February 22, 2021

Patients with TD who require continued treatment with an antipsychotic may benefit from atypical antipsychotics, such as risperidone, olanzapine, aripiprazole, and clozapine, as these agents seem to carry less risk for TD. Butyrophenones, diphenylbutylpiperidines, and phenothiazines are all first-generation (or typical) antipsychotics and carry a greater risk for TD. Therefore, these drugs should be avoided in patients with TD who require long-term antipsychotic treatment.

Learn more about the management of TD.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: